Unmatched Precision for Astigmatism Management and Premium Outcomes

The ALLY® System is equipped with unique adaptive technology that guides confident astigmatism management with unsurpassed precision for toric IOLs and arcuate incisions. Successfully managing astigmatism during cataract surgery is critical for delivering premium outcomes. Listen to Dr. Visco as she shares her journey and the premium outcomes achieved with the ALLY System.

Dr. Visco’s data speaks volumes: regardless of the lens, IntelliAxis Refractive Capsulorhexis® consistently delivers superior outcomes.1-2 A remarkable 98% of Toric IOL patients experience less than 0.50 D residual astigmatism, showcasing the system's precision and effectiveness.2

When incorporating arcuate incisions, she achieves 95.8% of patients with less than 0.50 D residual astigmatism.1 AI patients show no regression one-year post-op, highlighting the stability of incisions made with the ALLY System.

This revolutionary technology stands at the forefront of cataract surgery, ensuring that patients receive the best possible outcomes. Embrace the future of FLACS with ALLY.

Watch Dr. Visco's Testimonial Now

© 2023 LENSAR, Inc. All rights reserved. LENSAR, the LENSAR logo, Streamline, IntelliAxis, IntelliAxis Refractive Capsulorhexis, ALLY Adaptive Cataract Treatment System, and the ALLY Adaptive Cataract Treatment System logo are registered trademarks, and the LENSAR Cataract Laser with Augmented Reality logo, Intelligent Incisions, Augmented Reality, and Adaptive Intelligence are trademarks of LENSAR, Inc. All other trademarks are the property of their respective owners.

Contact Us: [email protected]
Website: https://lensar.com/
LinkedIn:   / lensar-inc-  
Facebook:   / lensarlaser  
Instagram:   / lensarlaser  
Twitter:   / lensar